IL6 and hepatocellular carcinoma: Besides HCC cell lines, other cell types were tested in present study and IL-6 treatment also enhanced PGRN expression in lung, cervical and breast cancer cell lines, suggesting IL-6-driven PGRN expression is a common phenomenon.